knowledge -WSS

knowledge

author：fashion 2025-10-02 01:09:00 - browse：4638

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Second House panel advances two

entertainment

WSS

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Criminal prosecution for violating HIPAA: an emerging threat

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Neutralizing antibodies against HIV shows promise in children

Case highlights the risks of experimental stem cell therapy

focus

knowledge

focus

Peter Hotez and the public health issue of online harassment

Venture capitalist Bob Kocher on the state of digital health

Apple is now the first public company to be valued at $3 trillion

California man arrested in connection with serial murders of Mexican strip club workers

Cancer drug shortages should be causing more outrage

What to know about a major upcoming Wegovy heart health study

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

HIV vaccine remains elusive. Immunologists keep trying new ideas

In Memoriam: Notable people who died in 2023

Data integrity in scientific journals requires "effort" by publishers, institutions

focus

Case highlights the risks of experimental stem cell therapy

Arc Institute generative AI designs new CRISPR systems

Another man arrested in connection with shooting at Kansas nightclub

Cytokinetics CEO stresses company can launch heart drug on its own

Arc Institute generative AI designs new CRISPR systems

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

hotspot

leisure time

entertainment

knowledge